glp 1 antagonist drugs GLP-1 Costs Explained: Managing Coverage Challenges The GLP-1 revolution: What UAB
Description
Hwang is also keeping her eye on how any change to compounded GLP-1 drugs may affect access in the long run
They are FDA-approved for obesity and increasingly used for other inflammatory conditions
10.2337/db23-0553 40 KahlesF.MeyerC.MollmannJ.DieboldS.FindeisenH
GIP is another incretin hormone
Malhotra has submitted a grant proposal to the National Institutes of Health to explore this issue
